Mesoblast Ltd Files June 2024 6-K Report

Ticker: MEOBF · Form: 6-K · Filed: Jun 4, 2024 · CIK: 1345099

Mesoblast LTD 6-K Filing Summary
FieldDetail
CompanyMesoblast LTD (MEOBF)
Form Type6-K
Filed DateJun 4, 2024
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: regulatory-filing, foreign-private-issuer

TL;DR

MESO files 6-K on June 3rd, check ASX for details.

AI Summary

On June 3, 2024, Mesoblast Limited announced a new release filed with the Australian Securities Exchange. This filing is a Form 6-K report for the month of June 2024, detailing information for the period ending June 4, 2024. The company is incorporated in Australia and its principal executive offices are located in Melbourne.

Why It Matters

This filing provides an update on Mesoblast Limited's regulatory and corporate activities, which could impact investor understanding of the company's current status and future prospects.

Risk Assessment

Risk Level: low — This filing is a routine report and does not contain significant new financial or operational information that would immediately alter risk.

Key Players & Entities

FAQ

What is the purpose of this Form 6-K filing?

The Form 6-K is a report of a Foreign Private Issuer filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of June 2024.

When was the new release announcement filed with the Australian Securities Exchange?

The new release announcement was filed on June 3, 2024.

Who is the Chief Executive Officer and Executive Director of Mesoblast Limited?

Silviu Itescu is the Chief Executive Officer and Executive Director of Mesoblast Limited.

Where are Mesoblast Limited's principal executive offices located?

Mesoblast Limited's principal executive offices are located at Level 38, 55 Collins Street, Melbourne 3000, Australia.

Does Mesoblast Limited file annual reports under Form 20-F or Form 40-F?

Yes, Mesoblast Limited files annual reports under Form 20-F.

Filing Stats: 252 words · 1 min read · ~1 pages · Grade level 14.1 · Accepted 2024-06-03 21:15:42

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly organized. Mesoblast Limited s Paul Hughes Paul Hughes Company Secretary Dated June 4, 2024 INDEX TO EXHIBITS Item 99.1 Press release of Mesoblast Ltd, dated June 3, 2024 . 99.2 Corporate presentation of Mesoblast Ltd, dated June 3, 2024

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing